OMEGA CRO was founded on 13 March 1997. Starting from the 1993 with the first release of regulations regarding clinical trials by Turkish Ministry of Health, Turkey as a new market speeds up to improve at clinical trials. OMEGA CRO aims to take advantage of Turkey's potential with respect to Medical Centres, investigators and patient population to carry out clinical trials. OMEGA CRO is also working on possible expansions to neighboring countries in Eastern Europe; like Romania, Bulgaria, and Greece; because of geographic advantages and in Middle East; like Egypt, Israel, Saudi Arabia. OMEGA CRO can see both the industry and investigator aspects of clinical trials. The company first pay exceptional attention to understand both sides' viewpoints and objectives, and then create valid and rational solutions to meet these needs and finally provide a spectrum of clinical research management services. OMEGA CRO provides an important inroad into Turkey and other regional countries with broad patient populations, highly qualified investigators and modern medical facilities for conducting trials in a wide range of therapeutic areas.
R&D
To view this information, you must subscribe to PL Intelligence.
Head office
OMEGA CRO
Güniz Sok. 32/12
Kavakl¿dere
Ankara
06700 Turkey